e-learning
resources
Paris 2018
Wednesday, 19.09.2018
What is new in idiopathic interstitial pneumonias?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Frailty is an independent predictor of number and length of hospitalizationsin patients with fibrotic ILD
S. Guler (Vancouver, Canada), J. Kwan (Vancouver, Canada), P. Wilcox (Vancouver, Canada), C. Ryerson (Vancouver, Canada)
Source:
International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Session:
What is new in idiopathic interstitial pneumonias?
Session type:
Poster Discussion
Number:
5244
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Guler (Vancouver, Canada), J. Kwan (Vancouver, Canada), P. Wilcox (Vancouver, Canada), C. Ryerson (Vancouver, Canada). Frailty is an independent predictor of number and length of hospitalizationsin patients with fibrotic ILD. 5244
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
SADL scale as a predictor of mortality in patients with ILD associated with Scleroderma
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
6MWT as useful predictor for long term survival after lung transplantation in patients with ILD
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020
Validation of bode index as a predictor of mortality in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1421-1429
Year: 2014
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Walking distance is a predictor of exacerbations in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Assessment of severity and prognosis in COPD: moving beyond percent of predicted
Source: Eur Respir J, 52 (2) 1801005; 10.1183/13993003.01005-2018
Year: 2018
Sleep duration is an independent determinant of metabolic impairment in COPD patients
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Weight loss as a predictor of mortality in patients with interstitial lung disease
Source: Eur Respir J, 52 (3) 1801289; 10.1183/13993003.01289-2018
Year: 2018
Male gender and fibrosis score on high-resolution computed tomography are independent poor prognostic factors of survival in patients with rheumatoid arthritis-related interstitial lung disease.
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Lung function reversibility as a predictor of disease progression in COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis?
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Cardio-vascular co-morbidities and severity of lung function impairment in a COPD cohort
Source: Eur Respir J 2006; 28: Suppl. 50, 160s
Year: 2006
The eNose as a predictor of disease severity and treatment response
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Is COPD an independent predictor of osteoporosis?
Source: International Congress 2015 – COPD: notable points
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept